Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis.

Aanaes K, Rasmussen N, Pressler T, Segelmark M, Johansen HK, Lindberg U, Høiby N, Carlsson M, Wieslander J, Buchwald C.

Scand J Immunol. 2012 Dec;76(6):573-9. doi: 10.1111/j.1365-3083.2012.02775.x.

2.

Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.

Carlsson M, Eriksson L, Pressler T, Kornfält R, Mared L, Meyer P, Wiik A, Wieslander J, Segelmark M.

J Cyst Fibros. 2007 May;6(3):228-33. Epub 2006 Dec 12.

3.

BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study.

Lindberg U, Carlsson M, Löfdahl CG, Segelmark M.

Clin Dev Immunol. 2012;2012:370107. doi: 10.1155/2012/370107. Epub 2012 Dec 30.

5.

Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.

Mahadeva R, Dunn AC, Westerbeek RC, Sharples L, Whitehouse DB, Carroll NR, Ross-Russell RI, Webb AK, Bilton D, Lomas DA, Lockwood CM.

Clin Exp Immunol. 1999 Sep;117(3):561-7.

6.

Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies.

Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S95-100.

PMID:
14740434
7.

Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis.

Dorlöchter L, Carlsson M, Olafsdottir EJ, Røksund OD, Rosendahl K, Fluge G.

J Cyst Fibros. 2004 Aug;3(3):179-83.

8.

Pseudomonas aeruginosa in cystic fibrosis: pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.

Carlsson M, Shukla S, Petersson AC, Segelmark M, Hellmark T.

J Cyst Fibros. 2011 Jul;10(4):265-71. doi: 10.1016/j.jcf.2011.03.004. Epub 2011 Apr 3.

9.

Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.

Zhao MH, Jayne DR, Ardiles LG, Culley F, Hodson ME, Lockwood CM.

QJM. 1996 Apr;89(4):259-65.

PMID:
8733512
10.

Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.

Sedivá A, Bartůnková J, Kolárová I, Hrusák O, Vávrová V, Macek M Jr, Lockwood CM, Dunn AC.

J Autoimmun. 1998 Apr;11(2):185-90.

PMID:
9650098
11.

BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.

Lindberg U, Carlsson M, Hellmark T, Segelmark M.

J Immunol Res. 2015;2015:947934. doi: 10.1155/2015/947934. Epub 2015 Jul 26.

12.

Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.

Rotschild M, Elias N, Berkowitz D, Pollak S, Shinawi M, Beck R, Bentur L.

Clin Exp Med. 2005 Jul;5(2):80-5.

PMID:
16096858
13.

BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing of E. coli DH5alpha in vitro.

Schultz H, Schinke S, Mosler K, Herlyn K, Schuster A, Gross WL.

Pediatr Pulmonol. 2004 Feb;37(2):158-64.

PMID:
14730661
14.
15.
16.

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin.

Cooper T, Savige J, Nassis L, Paspaliaris B, Neeson P, Neil J, Knight KR, Daskalakis M, Doery JC.

Rheumatol Int. 2000;19(4):129-36.

PMID:
10836522
17.

Anti-neutrophil cytoplasmic antibodies (ANCA) in serum and bronchoalveolar lavage fluids of cystic fibrosis patients and patients with idiopathic bronchiectasis.

Cobanoğlu N, Ozcelik U, Cetin I, Yalçin E, Doğru D, Kiper N, Bakkaloğlu A.

Turk J Pediatr. 2010 Jul-Aug;52(4):343-7.

PMID:
21043377
18.
19.

Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.

Aichele D, Schnare M, Saake M, Röllinghoff M, Gessner A.

Infect Immun. 2006 Aug;74(8):4708-14.

20.

Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis.

Lachenal F, Nkana K, Nove-Josserand R, Fabien N, Durieu I.

Eur Respir J. 2009 Nov;34(5):1079-85. doi: 10.1183/09031936.00006009. Epub 2009 May 14.

Supplemental Content

Support Center